ClinVar Miner

Submissions for variant NM_000218.3(KCNQ1):c.850_852del (p.Glu284del)

dbSNP: rs1064796353
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000486506 SCV000572986 likely pathogenic not provided 2017-02-15 criteria provided, single submitter clinical testing An in-frame deletion that is likely pathogenic was identified in the KCNQ1 gene. The c.850_852delGAG variant has not been published as pathogenic nor been reported as benign to our knowledge. c.850_852delGAG results in an in-frame deletion of a glutamic acid residue at position 284, denoted p.Glu284del. Multiple in-frame deletions in the KCNQ1 gene, as well as a pathogenic missense variant in this residue (E284K), have been reported in HGMD in association with LQTS (Stenson et al., 2014). Furthermore, the c.850_852delGAG variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). In summary, c.850_852delGAG in the KCNQ1 gene is interpreted as a likely pathogenic variant.
Labcorp Genetics (formerly Invitae), Labcorp RCV001248259 SCV001421730 pathogenic Long QT syndrome 2023-05-08 criteria provided, single submitter clinical testing This variant disrupts a region of the KCNQ1 protein in which other variant(s) (p.Glu284Lys) have been determined to be pathogenic (PMID: 14678125, 17470695; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 423306). This variant has not been reported in the literature in individuals affected with KCNQ1-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant, c.850_852del, results in the deletion of 1 amino acid(s) of the KCNQ1 protein (p.Glu284del), but otherwise preserves the integrity of the reading frame.
Ambry Genetics RCV002446944 SCV002680708 uncertain significance Cardiovascular phenotype 2019-11-07 criteria provided, single submitter clinical testing The c.850_852delGAG variant (also known as p.E284del) is located in coding exon 6 of the KCNQ1 gene. This variant results from an in-frame GAG deletion at nucleotide positions 850 to 852. This results in the in-frame deletion of a glutamic acid at codon 284, and is located in the transmembrane-spanning S5/pore domain. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.